Cameron graduated from Yale University with a BA in Linguistics in 2013. During his undergraduate career, he joined the laboratory of Drs. Christopher Breuer and Toshiharu Shinoka in the Vascular Biology and Therapeutics Program at the Yale School of Medicine. His work focused on the development of novel biodegradable scaffolds for vascular tissue engineering. In 2013, he relocated with the laboratory to Nationwide Children’s Hospital, where he was involved in the first FDA-approved clinical trial investigating the use of a tissue-engineered vascular graft for the surgical palliation of congenital heart defects. Between 2016 and 2019, Cameron earned a PhD in Biomedical Science at the Ohio State University. In 2019, he entered the Ohio State University College of Medicine’s Class of 2023. He is excited to experience firsthand the clinical processes related to cardiothoracic surgery and continue his research supporting the translation of tissue-engineering technologies to the pediatric population.